Compare GME & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GME | GKOS |
|---|---|---|
| Founded | 1996 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronics Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 8.7B |
| IPO Year | 2005 | 2015 |
| Metric | GME | GKOS |
|---|---|---|
| Price | $21.94 | $156.28 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 12 |
| Target Price | $13.50 | ★ $126.92 |
| AVG Volume (30 Days) | ★ 4.0M | 768.7K |
| Earning Date | 06-09-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 133.33 | N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | ★ $3,629,900,000.00 | $507,442,000.00 |
| Revenue This Year | $18.98 | $23.32 |
| Revenue Next Year | N/A | $27.43 |
| P/E Ratio | $33.67 | ★ N/A |
| Revenue Growth | N/A | ★ 32.33 |
| 52 Week Low | $19.94 | $73.16 |
| 52 Week High | $28.10 | $157.71 |
| Indicator | GME | GKOS |
|---|---|---|
| Relative Strength Index (RSI) | 48.12 | 69.73 |
| Support Level | $21.09 | $96.44 |
| Resistance Level | $22.02 | N/A |
| Average True Range (ATR) | 0.57 | 6.17 |
| MACD | 0.04 | 0.70 |
| Stochastic Oscillator | 43.88 | 78.97 |
GameStop Corp offers games, collectibles, and entertainment products through its stores and ecommerce platforms. Its products include Hardware and accessories offering new and pre-owned gaming platforms from the console manufacturers, Software offering new and pre-owned gaming software for current and certain prior generation consoles and sell a wide range of in-game digital currency, digital downloadable content and full-game downloads, and Collectibles consist of apparel, toys, trading cards, gadgets and other retail products for pop culture and technology enthusiasts and collectibles related services, such as submission services for the authentication and grading of trading cards. The company operates its business in three geographic segments: the United States, Australia, and Europe.
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.